БЛОГ

Jan 30, 2017

Pterostilbene an anticarcinogenic breakthrough

Posted by in categories: biotech/medical, innovation

Pterostilbene showing some interesting potential for treating cancer.


One of the most common forms of cancer in the hematologic system is Multiple myeloma (MM) which affects plasma cells, a type of white blood cell that produces antibodies. With advanced symptoms bone pain, bleeding, frequent infections, and anemia may occur.

In studies, Pterostilbene has shown anti-inflammatory and anticarcinogenic properties which has led to the improved function of healthy cells and the inhibition of malignant cells. So far its anticarcinogenic action has been reported for lung, breast and prostate cancers. Today we will look at the latest research showing how it could be used to treat cancer patients.

A better Resveratrol

As we already explaining through this dedicated website, Pterostilbene is a naturally occurring dietary compound, first discovered in 1977 by Langcake and Pryce. Pterostilbene is chemically related to resveratrol but with better bioavailability due to the presence of two methoxy groups which cause it to exhibit increased lipophilic and oral absorption. In animal studies, pterostilbene was shown to have 80% bioavailability compared to 20% for resveratrol suggesting it is a superior choice in direct comparison.

Read more

1

Comment — comments are now closed.

  • NIPSZX on January 31, 2017 7:11 pm

    I totally agree with the research on Pterostilbene. It has great potential as a future flavanoid. The medical research in the past has shown:

    +inhibits prostate cancer
    +inhibits CRC
    +daily high doses are toxic in mice
    +longer half life in vivo than resveratrol
    +very high bioavailability

    The only problem is that medical research seems to favor a new product in all of it’s trials in the early running of the research. That is why I always wait 12 years after a new product is released before supplementing. The same good things were said about resveratrol during it’s first ten years of research. Now resveratrol has some medical research history late in it’s life that proves:

    -5 fold reduced endurance
    –cytotoxic to normal cells
    –inhibits the proliferation of normal human killer cells
    –when administered at doses described to be effective in treating tumor cells, it has cytotoxic effects on human retinal pigment epithelial cells and also induces apoptosis and (-) necrosis of the cells.

    It is similar to buying a car. After owning your car for 10–20 years, you will be able to give the pros and cons. However, when the car is first released, the researchers talk about the nice paint and the smooth ride. By the time 20 years go by, the researchers are no longer talking about the 1997 model, they are talking about the 2017 model, that happens to cost more, but might have more problems. But, then again, it might not have as many problems. Only time will tell.

    You can research any of the above information to validate with Google and NCBI. If you are the administrator of the Lifeboat site and you are looking for somebody to help with your research please comment below or contact me. Thanks and your welcome.